瑞马唑仑

瑞马唑仑（CAS 308242-62-8）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.Remimazolam is an ultra-short acting benzodiazepine used intravenously for induction and maintenance of sedation for adults undergoing short term procedures not requiring general anesthesia. Remimazolam sedation has not been associated with serum aminotransferase elevations and has not been linked to cases of clinically apparent liver injury.

同义词与商品名

Remimazolam; 308242-62-8; CNS 7056; CNS-7056; ONO-2745; 7V4A8U16MB; ONO2745; 4H-Imidazo(1,2-a)(1,4)benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ester, (4S)-; CNS7056; remimazolamum; RefChem:57866; N05CD14; methyl 3-((4S)-8-bromo-2-methyl-6-pyridin-2-yl-4H-imidazo(1,2-a)(1,4)benzodiazepin-4-yl)propanoate; Byfavo (TN); Remimazolam [INN]; UNII-7V4A8U16MB

公开数据库对它的描述

Remimazolam · CAS 308242-62-8 · C21H19BrN4O2. UNII 7V4A8U16MB.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。